Literature DB >> 18838445

Does analysis using "last observation carried forward" introduce bias in dementia research?

Frank J Molnar1, Brian Hutton, Dean Fergusson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18838445      PMCID： PMC2553855          DOI： 10.1503/cmaj.080820

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

Authors:  P S Aisen; K L Davis; J D Berg; K Schafer; K Campbell; R G Thomas; M F Weiner; M R Farlow; M Sano; M Grundman; L J Thal
Journal:  Neurology       Date:  2000-02-08       Impact factor: 9.910

2.  Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases.

Authors:  K Unnebrink; J Windeler
Journal:  Stat Med       Date:  2001-12-30       Impact factor: 2.373

3.  Accounting for dropout bias using mixed-effects models.

Authors:  C H Mallinckrodt; W S Clark; S R David
Journal:  J Biopharm Stat       Date:  2001 Feb-May       Impact factor: 1.051

4.  The case of the missing data: methods of dealing with dropouts and other research vagaries.

Authors:  David L Streiner
Journal:  Can J Psychiatry       Date:  2002-02       Impact factor: 4.356

5.  Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations.

Authors:  Craig H Mallinckrodt; S W Scott Clark; Raymond J Carroll; Geert Molenbergh
Journal:  J Biopharm Stat       Date:  2003-05       Impact factor: 1.051

6.  Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.

Authors:  G L Gadbury; C S Coffey; D B Allison
Journal:  Obes Rev       Date:  2003-08       Impact factor: 9.213

7.  Vitamin E and donepezil for the treatment of mild cognitive impairment.

Authors:  Ronald C Petersen; Ronald G Thomas; Michael Grundman; David Bennett; Rachelle Doody; Steven Ferris; Douglas Galasko; Shelia Jin; Jeffrey Kaye; Allan Levey; Eric Pfeiffer; Mary Sano; Christopher H van Dyck; Leon J Thal
Journal:  N Engl J Med       Date:  2005-04-13       Impact factor: 91.245

Review 8.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.

Authors:  Krista L Lanctôt; Nathan Herrmann; Kenneth K Yau; Lyla R Khan; Barbara A Liu; Maysoon M LouLou; Thomas R Einarson
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

9.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors:  Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal:  JAMA       Date:  2004-01-21       Impact factor: 56.272

10.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272
View more
  39 in total

1.  Drugs for Alzheimer's disease: are they effective?

Authors:  David A Casey; Demetra Antimisiaris; James O'Brien
Journal:  P T       Date:  2010-04

2.  Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Authors:  Krista L Lanctôt; Ryan D Rajaram; Nathan Herrmann
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

3.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

4.  How to optimize participant retention and complete follow-up in surgical research.

Authors:  Manrajr Kaur; Sheila Sprague; Teegan Ignacy; Achilles Thoma; Mohit Bhandari; Forough Farrokhyar
Journal:  Can J Surg       Date:  2014-12       Impact factor: 2.089

5.  Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.

Authors:  Gary E Gibson; José A Luchsinger; Rosanna Cirio; Huanlian Chen; Jessica Franchino-Elder; Joseph A Hirsch; Lucien Bettendorff; Zhengming Chen; Sarah A Flowers; Linda M Gerber; Thomas Grandville; Nicole Schupf; Hui Xu; Yaakov Stern; Christian Habeck; Barry Jordan; Pasquale Fonzetti
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  The effects of the calcium-magnesium-bicarbonate content in thermal mineral water on chronic low back pain: a randomized, controlled follow-up study.

Authors:  Tamás Gáti; Ildikó Katalin Tefner; Lajos Kovács; Katalin Hodosi; Tamás Bender
Journal:  Int J Biometeorol       Date:  2018-01-10       Impact factor: 3.787

7.  The Effect of Workforce Mobility on Intervention Effectiveness Estimates.

Authors:  Justin Manjourides; Emily H Sparer; Cassandra A Okechukwu; Jack T Dennerlein
Journal:  Ann Work Expo Health       Date:  2018-03-12       Impact factor: 2.179

8.  Effectiveness of a specific care plan in patients with Alzheimer's disease: cluster randomised trial (PLASA study).

Authors:  Fati Nourhashemi; Sandrine Andrieu; Sophie Gillette-Guyonnet; Bruno Giraudeau; Christelle Cantet; Nicola Coley; Bruno Vellas
Journal:  BMJ       Date:  2010-06-03

9.  Have last-observation-carried-forward analyses caused us to favour more toxic dementia therapies over less toxic alternatives? A systematic review.

Authors:  Frank J Molnar; Malcolm Man-Son-Hing; Brian Hutton; Dean A Fergusson
Journal:  Open Med       Date:  2009-03-24

10.  Missing outcomes in randomized trials: addressing the dilemma.

Authors:  Douglas G Altman
Journal:  Open Med       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.